Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

NCT00666341 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Type I-Allergy

Interventions

DRUG: placebo
BIOLOGICAL: rPhleum
BIOLOGICAL: rPhleum
BIOLOGICAL: rPhleum
BIOLOGICAL: rPhleum

Sponsor

Allergopharma GmbH & Co. KG